本页面由Tiger Trade Technology Pte. Ltd.提供服务

Agios Pharmaceuticals, Inc.

27.68
-0.5100-1.81%
盘后27.800.1200+0.43%18:43 EST
成交量:102.04万
成交额:2,845.26万
市值:16.14亿
市盈率:-3.89
高:28.38
开:28.14
低:27.47
收:28.19
52周最高:46.00
52周最低:22.24
股本:5,831.38万
流通股本:5,134.85万
量比:1.22
换手率:1.99%
股息:- -
股息率:- -
每股收益(TTM):-7.1203
每股收益(LYR):-7.1203
净资产收益率:-30.20%
总资产收益率:-19.94%
市净率:1.35
市盈率(LYR):-3.89

数据加载中...

2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/12

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/10/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities